{"id":"W2949991172","doi":"10.1097/01.hs9.0000567032.31064.27","title":"PB2137 SUBGROUP ANALYSIS OF PATIENTS FROM CANADA AND THE UNITED STATES IN THE PHASE 3 FIRST TRIAL IN TRANSPLANT‐INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Leukemia & Lymphoma Society of Canada; McGill University Health Centre; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Dalhousie University","funders":"","keywords":"Lenalidomide; Medicine; Thalidomide; Multiple myeloma; Internal medicine; Melphalan; Prednisone; Progression-free survival; Surgery; Gastroenterology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003002035,0.0009921929,0.002627431,0.0009194529,0.0009834274,0.001446607,0.0009723161,0.001010911,0.00401228],"category_scores_gemma":[0.005236926,0.0003176087,0.006356977,0.00187079,0.0004071688,0.0003982193,0.0008167999,0.001110794,0.0002872186],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003885661,"about_ca_system_score_gemma":0.008528958,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.2675471,"about_ca_topic_score_gemma":0.5027285,"domain_scores_codex":[0.9974712,0.0007437809,0.0002859019,0.0004320669,0.0004266824,0.0006404615],"domain_scores_gemma":[0.9971409,0.0007610008,0.0007208973,0.0004373616,0.0004950793,0.000444737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1751316,0.000292414,0.7154434,0.001440329,0.05643656,0.0006321438,0.000427696,0.001757802,0.001954894,0.0005197552,0.01191124,0.03405205],"study_design_scores_gemma":[0.0197999,0.003566843,0.9170955,0.0005629034,0.04272618,0.0007162847,0.000843576,0.00227195,0.0006857544,0.000778625,0.01081567,0.0001368746],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9659919,0.01877171,0.000429669,0.0008474348,0.0002218731,0.0005077611,0.009470034,0.00003120367,0.003728358],"genre_scores_gemma":[0.9911032,0.001583984,0.0002158869,0.0006471496,0.00008949191,0.0002555297,0.0051937,0.00002781408,0.0008833436],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2675471,"threshold_uncertainty_score":0.5319797,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01440336199869468,"score_gpt":0.2654622143583468,"score_spread":0.2510588523596521,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}